SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-023647
Filing Date
2016-08-09
Accepted
2016-08-09 16:00:48
Documents
53
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q myok-10q_20160630.htm 10-Q 1491217
2 EX-31.1 myok-ex311_6.htm EX-31.1 14355
3 EX-31.2 myok-ex312_9.htm EX-31.2 14339
4 EX-32.1 myok-ex321_8.htm EX-32.1 8284
  Complete submission text file 0001564590-16-023647.txt   4338987

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT myok-20160630.xml EX-101.INS 773432
6 XBRL TAXONOMY EXTENSION SCHEMA myok-20160630.xsd EX-101.SCH 36601
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE myok-20160630_cal.xml EX-101.CAL 30892
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE myok-20160630_def.xml EX-101.DEF 110249
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE myok-20160630_lab.xml EX-101.LAB 257167
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myok-20160630_pre.xml EX-101.PRE 191477
Mailing Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-741-0900
MyoKardia Inc (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37609 | Film No.: 161817785
SIC: 2834 Pharmaceutical Preparations